Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial-Reference-Cited by-同舟云学术

Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial

Published:2016-12-23 Issue:4 Volume:55 Page:458-464
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Campbell Craig¹,McMillan Hugh J.²,Mah Jean K.³,Tarnopolsky Mark⁴,Selby Kathryn⁵,McClure Ty⁶,Wilson Dawn M.⁶,Sherman Matthew L.⁶,Escolar Diana⁷,Attie Kenneth M.⁶

Affiliation:

1. Pediatrics, Epidemiology and Clinical Neurological Sciences; Western University; London Ontario Canada

2. Children's Hospital of Eastern Ontario; University of Ottawa; Ottawa Ontario Canada

3. Alberta Children's Hospital; University of Calgary; Calgary Alberta Canada

4. McMaster University Medical Centre; Hamilton Ontario Canada

5. British Columbia Children's Hospital; University of British Columbia; Vancouver British Columbia Canada

6. Acceleron Pharma; Cambridge Massachusetts USA

7. Kennedy Krieger Institute; Johns Hopkins Medical School; Baltimore Maryland USA

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mus.25268/fullpdf

Reference32 articles.

1. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management;Bushby;Lancet Neurol,2010

2. Population frequencies of inherited neuromuscular diseases-a world survey;Emery;Neuromuscul Disord,1991

3. Duchenne muscular dystrophy: a 30-year population-based incidence study;Dooley;Clin Pediatr (Phila),2010

4. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation;Eagle;Neuromuscul Disord,2002

5. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member;McPherron;Nature,1997

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current Landscape of Pharmacotherapies for Sarcopenia;Drugs & Aging;2024-02-05

2. Novel Mammalian Ubiquitous Promoter Isolated from Bovine MSTN Gene Promoter;2024-01-17

3. The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy;Neurology and Therapy;2024-01-08

4. Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age;Nutrients;2023-12-25

5. Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management;World Journal of Gastroenterology;2023-12-14